| ID | Analyse | Domein | Recipiënt ▲ | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINC (1) | LOINC (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 21710 | T cellen, T4/T8 CD4/CD8 ratio, Helper-Inducer/Supressor-Killer ratio, Lymfocytensubsets | EDTA |
23 (1) | – | 8124-0 | – | › | |||
| 21700 | T,B en NK cellen Lymfocytensubsets, Natural Killer cellen, NK-cellen | EDTA |
24 (1) | – | 18267-5 | – | › | |||
| 27167 | T3 urine aml Triiodothyronine | 24-uurs urinecollectie |
214 (8,9) | – | 97165-5 | – | › | |||
| 27169 | T4 urine aml Tetraiodothyronine, Thyroxine | 24-uurs urinecollectie |
282 (11,8) | – | 97167-1 | – | › | |||
| 4311 | Taenia | Serum |
195 (8,1) | – | – | – | › | |||
| 28550 | Telling-formule LV Leukocyten/erytrocyten telling CSV, Leukocyten/erytrocyten telling LV, WBC/RBC telling CSV | Lumbaalvocht (CSV) |
4 (0,1) | – | – | – | › | |||
| 28780 | Telling-formule AV/PV | Punctievocht (Ascites / Pleura / Pericard) |
15 (0,6) | – | – | – | › | |||
| 28720 | Telling + formule GV | Gewrichtsvocht |
25 (1,1) | – | – | – | › | |||
| 57435 | Tellurium /g creatinine Te | Urine |
173 (7,2) | – | – | – | › | |||
| 58247 | Tetrahydrofuraan/u THF | Urine |
165 (6,9) | – | – | – | › | |||
| 57510 | Thallium /g creatinine Tl | Urine |
229 (9,6) | – | 13469-2 | 42226-1 | › | |||
| 58150 | Thiocyanaat/g creatinine SCN | Urine |
332 (13,8) | – | 21562-4 | – | › | |||
| 58245 | Thiodiglycolzuur | Urine |
212 (8,8) | – | – | – | › | |||
| 5692 | Thiopental S Pentothal | Serum |
– | – | – | › | ||||
| 4715 | Tick Born Encephalitis Central european encephalitis, Early summer encephalitis, Frühsommermeningoenzephalitis (FSME) | Serum |
139 (5,8) | – | – | – | › | |||
| 57570 | Tin / g creatinine Sn | Urine |
164 (6,8) | – | 17710-5 | – | › | |||
| 57905 | Tolueen/ g crea | Urine |
237 (9,9) | – | – | – | › | |||
| 57263 | Tot. urin. metanefrines | Urine |
147 (6,1) | – | 11139-3 | – | › | |||
| 24358 | Toxo IgG aviditeit Toxoplasmose | Serum |
407 (17) | – | 34422-6 | – | › | |||
| 24425 | Toxo IgG zw./infectie? Toxoplasmose | Serum |
2 (0,1) | – | – | – | › | |||
| 24424 | Toxo IgM zw./infectie? Toxoplasmose | Serum |
2 (0,1) | – | – | – | › | |||
| 24371 | Toxoplasma confirm. AML Toxoplasmose | Serum |
164 (6,8) | – | – | – | › | |||
| 24421 | Toxoplasma IgG zwanger Toxoplasmose | Serum |
2 (0,1) | – | – | – | › | |||
| 24420 | Toxoplasma IgM zwanger Toxoplasmose | Serum |
2 (0,1) | – | – | – | › | |||
| 24364 | Toxoplasmose dier Toxoplasma IgG (veterinair), Toxoplasma IgM (veterinair), Toxoplasmose | Serum |
113 (4,7) | – | – | – | › | |||
| 29677 | Trich.vag.DNA op urine | First voided urine |
53 (2,2) | – | 92685-7 | – | › | |||
| 29671 | Trich.vag.PCR op Swab | DNA-wisser |
48 (2) | – | 69937-1 | – | › | |||
| 29678 | Trich.vaginalis DNA (CR) | Varia / Diversen |
163 (6,8) | – | – | – | › | |||
| 57780 | Trichloorazijnzuur/g crea | Urine |
191 (8) | – | – | – | › | |||
| 57770 | Trichloorethanol/g creat. | Urine |
200 (8,4) | – | – | – | › | |||
| 8256 | Triethylamine TEA | Urine |
375 (15,6) | – | – | – | › | |||
| 4339 | Tryp.bruc. gambiense | Serum |
– | – | – | › | ||||
| 25360 | TSH-curve | Serum (4×) |
– | – | – | › | ||||
| 57930 | TTCA g/creat. TTCA | Urine |
188 (7,8) | – | – | – | › | |||
| 6013 | Tuberculose QuantiferonTB IGRA, Interferon Gamma Release Assay, Quantiferon | Heparine (Lithium-heparinebuis) (2×) |
67 (2,8) | – | 71775-1 | – | › | |||
| 31203 | Tweede triage (12 maand) | ThinPrep (Cervix- / Vloeistofcytologie) |
241 (10) | – | – | – | › |
